Patient Adherence to Fecal Calprotectin Testing Is Low Compared to Other Commonly Ordered Tests in Patients With Inflammatory Bowel Disease

BACKGROUND: Limited data exist on adherence to fecal calprotectin (FCP) testing in patients with inflammatory bowel disease. METHODS: Completion rates for patients who had at least one FCP test ordered (n = 3082) and a subgroup with C-reactive protein, complete blood count, and Clostridium difficile...

Descripción completa

Detalles Bibliográficos
Autores principales: Khakoo, Nidah S, Lewis, Ayanna, Roldan, Giovanni A, Al Khoury, Alex, Quintero, Maria A, Deshpande, Amar R, Kerman, David H, Damas, Oriana M, Abreu, Maria T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Observations and Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9802323/
https://www.ncbi.nlm.nih.gov/pubmed/36776647
http://dx.doi.org/10.1093/crocol/otab028
Descripción
Sumario:BACKGROUND: Limited data exist on adherence to fecal calprotectin (FCP) testing in patients with inflammatory bowel disease. METHODS: Completion rates for patients who had at least one FCP test ordered (n = 3082) and a subgroup with C-reactive protein, complete blood count, and Clostridium difficile tests also ordered (n = 1563) were analyzed. RESULTS: More patients completed blood than stool tests, with FCP having the poorest adherence of all tests analyzed. Older patients had higher FCP completion rates. No differences were noted in completion rates across age, gender, or ethnicity for blood tests. CONCLUSIONS: Further studies are needed to develop strategies that improve the uptake of FCP.

Ejemplares similares